The EDC-Free Europe coalition is urging the European Commission to propose the non-renewal of fenoxaprop-P-ethyl and fludioxonil. The pesticides have been recently defined recently as substances with endocrine-disrupting properties by the European Food Safety Authority (EFSA).
EFSA’s conclusions on the peer review of fludioxonil, show that the substance meets the endocrine disruption criteria for humans and wild mammals via the EAS-modalities. This endocrine disruption leads to delayed sexual maturation, decreased anogenital distance in males and increased oestrus cycle in females. In the case of fenoxaprop-P-ethyl EFSA concluded that this substance is an endocrine disruptor for humans through the A-modality test. Specifically, this substance was found to induce changes in the weights of the prostate, epididymis, and testes, alongside alterations in testicular weight.
These substances, initially approved until 2018 and later extended until 2025, pose a serious public health risk. Keeping these substances on the market, with the new evidence on their endocrine disrupting properties, directly contradicts the objective of Regulation 1107/2009, concerning the placing of plant protection products on the market, to ensure a high level of protection for human health and the environment, in line with the precautionary principle.
Read the letter here.
